Literature DB >> 30926221

An investigator's introduction to statistical considerations in clinical trials.

Kathryn Winter1, Stephanie L Pugh2.   

Abstract

The purpose of this paper is to provide an introduction for investigators to many of the statistical considerations for clinical trials that will aid in their collaborations with statisticians for clinical trial research endeavors and when reading the clinical trials literature. The purpose of this paper is not to turn a physician into a statistician, that takes formal training and education, as well as day in and day out immersion in the statistical design and analysis of clinical trials, hence statistician as a profession. Successful clinical trials, not to be confused with only positive clinical trials, are ones that are well designed to answer the trial question, well conducted, and appropriately reported and published, regardless of the results. Physicians and statisticians each play integral roles in the realm of clinical trials and successful clinical trials are the result of collaborations between physicians and statisticians from the beginning of an idea through the manuscript publication.
Copyright © 2018. Published by Elsevier Inc.

Entities:  

Keywords:  Analyses; Determining sample size; Statistical considerations

Mesh:

Year:  2019        PMID: 30926221      PMCID: PMC6959125          DOI: 10.1016/j.urolonc.2018.12.025

Source DB:  PubMed          Journal:  Urol Oncol        ISSN: 1078-1439            Impact factor:   3.498


  12 in total

Review 1.  Multiple imputation: a primer.

Authors:  J L Schafer
Journal:  Stat Methods Med Res       Date:  1999-03       Impact factor: 3.021

2.  Radiotherapy and short-term androgen deprivation for localized prostate cancer.

Authors:  Christopher U Jones; Daniel Hunt; David G McGowan; Mahul B Amin; Michael P Chetner; Deborah W Bruner; Mark H Leibenhaut; Siraj M Husain; Marvin Rotman; Luis Souhami; Howard M Sandler; William U Shipley
Journal:  N Engl J Med       Date:  2011-07-14       Impact factor: 91.245

Review 3.  Principles of clinical trial design.

Authors:  S Piantadosi
Journal:  Semin Oncol       Date:  1988-10       Impact factor: 4.929

4.  Surrogate endpoints in clinical trials: definition and operational criteria.

Authors:  R L Prentice
Journal:  Stat Med       Date:  1989-04       Impact factor: 2.373

5.  Missing data methods in longitudinal studies: a review.

Authors:  Joseph G Ibrahim; Geert Molenberghs
Journal:  Test (Madr)       Date:  2009-05-01       Impact factor: 2.345

6.  Advances in analysis of longitudinal data.

Authors:  Robert D Gibbons; Donald Hedeker; Stephen DuToit
Journal:  Annu Rev Clin Psychol       Date:  2010       Impact factor: 18.561

Review 7.  Biostatistics in clinical trials: Part 2. Determining sample sizes for clinical trials.

Authors:  S S Ellenberg
Journal:  Oncology (Williston Park)       Date:  1989-08       Impact factor: 2.990

8.  Effect of Standard vs Dose-Escalated Radiation Therapy for Patients With Intermediate-Risk Prostate Cancer: The NRG Oncology RTOG 0126 Randomized Clinical Trial.

Authors:  Jeff M Michalski; Jennifer Moughan; James Purdy; Walter Bosch; Deborah W Bruner; Jean-Paul Bahary; Harold Lau; Marie Duclos; Matthew Parliament; Gerard Morton; Daniel Hamstra; Michael Seider; Michael I Lock; Malti Patel; Hiram Gay; Eric Vigneault; Kathryn Winter; Howard Sandler
Journal:  JAMA Oncol       Date:  2018-06-14       Impact factor: 31.777

9.  Surrogate End Points for All-Cause Mortality in Men With Localized Unfavorable-Risk Prostate Cancer Treated With Radiation Therapy vs Radiation Therapy Plus Androgen Deprivation Therapy: A Secondary Analysis of a Randomized Clinical Trial.

Authors:  Trevor J Royce; Ming-Hui Chen; Jing Wu; Marian Loffredo; Andrew A Renshaw; Philip W Kantoff; Anthony V D'Amico
Journal:  JAMA Oncol       Date:  2017-05-01       Impact factor: 31.777

10.  Surrogate endpoints.

Authors:  S S Ellenberg
Journal:  Br J Cancer       Date:  1993-09       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.